JAZZ
Price
$131.72
Change
+$2.06 (+1.59%)
Updated
Sep 3 closing price
Capitalization
7.99B
62 days until earnings call
ROIV
Price
$12.59
Change
+$0.20 (+1.61%)
Updated
Sep 3 closing price
Capitalization
8.59B
74 days until earnings call
Interact to see
Advertisement

JAZZ vs ROIV

Header iconJAZZ vs ROIV Comparison
Open Charts JAZZ vs ROIVBanner chart's image
Jazz Pharmaceuticals
Price$131.72
Change+$2.06 (+1.59%)
Volume$654.87K
Capitalization7.99B
Roivant Sciences
Price$12.59
Change+$0.20 (+1.61%)
Volume$10.39M
Capitalization8.59B
JAZZ vs ROIV Comparison Chart in %
Loading...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAZZ vs. ROIV commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAZZ is a Buy and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (JAZZ: $131.72 vs. ROIV: $12.59)
Brand notoriety: JAZZ and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAZZ: 90% vs. ROIV: 198%
Market capitalization -- JAZZ: $7.99B vs. ROIV: $8.59B
JAZZ [@Biotechnology] is valued at $7.99B. ROIV’s [@Biotechnology] market capitalization is $8.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAZZ’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • JAZZ’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAZZ’s TA Score shows that 6 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • JAZZ’s TA Score: 6 bullish, 3 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ROIV.

Price Growth

JAZZ (@Biotechnology) experienced а +5.86% price change this week, while ROIV (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

JAZZ is expected to report earnings on Nov 05, 2025.

ROIV is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.59B) has a higher market cap than JAZZ($7.99B). JAZZ has higher P/E ratio than ROIV: JAZZ (15.38) vs ROIV (1.97). JAZZ YTD gains are higher at: 6.959 vs. ROIV (6.424). JAZZ has higher annual earnings (EBITDA): 372M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. JAZZ (1.67B). ROIV has less debt than JAZZ: ROIV (99.7M) vs JAZZ (5.43B). JAZZ has higher revenues than ROIV: JAZZ (4.09B) vs ROIV (23.2M).
JAZZROIVJAZZ / ROIV
Capitalization7.99B8.59B93%
EBITDA372M-1.18B-32%
Gain YTD6.9596.424108%
P/E Ratio15.381.97782%
Revenue4.09B23.2M17,616%
Total Cash1.67B4.5B37%
Total Debt5.43B99.7M5,449%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAZZROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 25 days ago
56%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
51%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BHYB54.720.50
+0.93%
Xtrackers USD High Yld BB-B ex Fin ETF
LTTI19.180.17
+0.87%
FT Vest 20+ Year Treasury & Target Income ETF
LEAD73.610.13
+0.18%
Siren DIVCON Leaders Dividend ETF
NZUS33.56N/A
N/A
SPDR MSCI USA Climate Paris Aligned ETF
PJP92.49-0.01
-0.01%
Invesco Pharmaceuticals ETF

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with TECH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+1.59%
TECH - JAZZ
42%
Loosely correlated
-0.15%
FTRE - JAZZ
41%
Loosely correlated
+6.79%
ROIV - JAZZ
39%
Loosely correlated
+1.61%
DAWN - JAZZ
39%
Loosely correlated
+1.08%
RGNX - JAZZ
36%
Loosely correlated
+8.11%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.61%
IMVT - ROIV
60%
Loosely correlated
+10.82%
ACLX - ROIV
54%
Loosely correlated
+2.11%
CRNX - ROIV
53%
Loosely correlated
+4.05%
KYMR - ROIV
51%
Loosely correlated
+6.41%
OCUL - ROIV
50%
Loosely correlated
+1.89%
More